Obstruction of the fetal trachea causes the lungs to expand with accumulated liquid.
Introduction
The growth and development of the fetal lung is dependent upon adequate distension of the future airways with liquid. This liquid is secreted into the lung lumen and exits the lung via the fetal trachea (9) . Thus, obstruction of the fetal trachea causes secreted liquid to accumulate within the future airways, causing the lungs to expand (2;9;12). The increase in lung expansion resulting from short periods (<7 days) of tracheal obstruction (TO) is a potent stimulus for fetal lung growth (11;26) . In contrast, the drainage of lung liquid results in lung deflation and the complete cessation of fetal lung growth (2;25) .
Previous studies have shown that the increase in lung growth induced by TO follows a distinct time course and that this growth is essentially complete within 7 days in fetal sheep (11;26) . In addition, we have shown that the increase in DNA synthesis rates is maximal at 2 days following TO, indicating that the signal(s) responsible for initiating the cellular proliferation are probably highest at this point (26) . We hypothesised that this time period (< 2 days) would be optimal for attempting to identify factors responsible for initiating the increase in fetal lung growth induced by TO. Thus, the aim of our study was to identify genes that are differentially expressed in response to 36-hours of increased lung expansion in fetal sheep. We have used Differential Display Reverse Transcription Polymerase Chain reaction (DD RT-PCR) (15;16) to characterise differential changes in gene expression in lung tissue following an increase in lung expansion (for review see 36) . Control lung tissue was compared to lung tissue exposed to increased lung expansion obtained from the same fetus. This was achieved by ligating the left bronchus, as previously described (23) , while the right lung was maintained at a control level of expansion.
In this study we report the identification of one gene, calmodulin 2 (CALM2), that is differentially expressed in response to an increase in fetal lung expansion. Calmodulin is a primary mediator of calcium signaling (3) and is a rate-limiting component that regulates LCMP-00202-2001 R2 4 cellular proliferation and differentiation in a variety of systems (19;22) . Our results suggest that enhanced CALM2 expression in the fetal lung may be an important component of the stretch-induced increase in fetal lung growth.
Materials and Methods
Surgical procedures: Aseptic surgery was performed on 2 pregnant, date-mated, Merino x Border Leicester ewes at 112 days of gestation (term ~145 days). Anesthesia of the ewe and fetus was induced with sodium thiopentone (1g, i.v.) and maintained by continuous inhalation of halothane (0.5-2% in O 2 and NO 2 : 50:50 vol/vol). The fetal head and neck was exposed via a hysterotomy and saline-filled polyvinyl catheters were inserted into the fetal carotid artery, jugular vein and into the amniotic sac to monitor fetal well being. Two largebore silicone rubber catheters were also inserted into the mid-cervical trachea; one directed toward the lungs and the other directed towards, but not entering, the fetal larynx. A third catheter (polyvinyl) was inserted into the lower trachea and subsequently fed into the left bronchus (see below). The left bronchus of the fetus was exposed, via a right thoracotomy, and a silk ligature placed around it as previously described (23) . The tip of the polyvinyl catheter, previously inserted into the lower trachea, was fed into the left bronchus and its position was confirmed by palpation before the ligature was tied. All catheters were exteriorised from the ewe and all tracheal catheters, including the left bronchial catheter, were joined to form a continuous tracheal loop that allowed the normal flow of liquid into and out of both lungs (10) . Thus, liquid was allowed to flow into and out of the left lung during the recovery period. The ewe and fetus were given at least 5 days to recover from the surgical procedure before the start of the experimental protocol. This ensured that a period of at least 5 days separated the surgical procedure from the period of increased left lung expansion to minimi ze the detection of genes affected by the surgical procedure.
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Experimental Protocol: At 126 days of gestation (~83% of gestation; term is ~147 days), , the left bronchus was obstructed for 36 hours, by occluding the left bronchial catheter, to increase expansion of the left lung. Complete obstruction was confirmed by measuring the increase in intra-luminal pressure within the left lung (26) . A previous study in our laboratory (23) has shown that obstruction of the left bronchus and over-expansion of the left lung for 25 days does not cause significant mediastinal shift and encroach upon the right side of the chest. Rather, expansion and growth of the left lung occurs in a caudal direction, causing eversion of the diaphragm on the left side (23) . At 128 days of gestation, after 36 hours of left bronchus obstruction (LBO), the fetal lung was drained of liquid immediately before the fetus and ewe were humanely killed with an overdose of sodium pentobarbitone (iv). The fetus was weighed, the fetal lungs removed, and the left and right lungs separated and The amplified cDNA fragments, which represented subsets of the original mRNA pool, were separated by electrophoresis using a 6% polyacrylamide sequencing gel. The gel was then mounted on filter paper (Whatmann, England), dried at 80 0 C for 2 hrs, and exposed to autoradiographic film (Kodak Biomax ML). Differentially expressed bands were identified by visual inspection of the autoradiograph and excised from the gel using sterile razor blades. They were placed in 100µl of DEPC-treated H 2 O at room temperature for 15 mins, and then boiled for 15 mins. The eluted DNA fragments were then re-amplified using the same PCR reaction conditions, primers and reagents as stated above, without the radiolabelled α 35 S-dATP and with 20mM dNTP's. The reaction mixtures were purified (Wizard PCR preps; Promega) and ligated into a plasmid vector (PGEM T-Easy, Promega).
The cDNA inserts were sequenced using dye terminator mix (Big Dye, Perkin Elmer) and an automated sequencer. Comparison of the DNA sequence with the GenBank database was undertaken using the BLAST alignment algorithm provided by the NIH.
Northern blot analysis:
Confirmation that the identified cDNA fragments are differentially expressed in response to an increase in fetal lung expansion was made by Northern blot analysis using lung tissue collected from (1) the right (control) and left (expanded) lungs of fetuses exposed to left bronchus obstruction (LBO; n = 2) and (2) a separate group of 20 fetal sheep. The latter group of fetal sheep were exposed to either 0 (control, n=5), 2 (n=5), 4 (n=5) or 10 (n=5) days of increased lung expansion induced by TO with all experiments terminating on 127-128 days of gestation. The experimental protocols and the changes in lung weights, DNA synthesis rates and lung DNA and protein contents for each of these fetuses has been previously described (13;26) .
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Total RNA was extracted from all fetal lung tissue samples and the mRNA levels, complimentary to the isolated cDNA fragments, were measured by Northern blot analysis as described previously (17) . Briefly, total RNA was extracted from fetal lung tissue using a modified version of the guanidine thiocyanate-cesium chloride method ( The photographic emulsion was developed using D-19 developer (Kodak) and fixed using Kodak fixer. The slides were then rinsed in distilled water and the sections counter-stained using Cresyl violet. To calculate the proportion of CALM2 labeled cells, approximately 500 cells in total were counted from each animal using sections from at least 3 different locations within the lung. These tissue sections were viewed under a light microscope at a magnification of x100.
The cDNA template used to generate the RNA probes was a 115bp fragment of the CALM2 cDNA fragment isolated using DD RT-PCR. This fragment is specific for CALM2 and encoded most of the 3' untranslated region (see fig. 1 ). The fragment was generated by PCR, using specific primers (5', ACAAATGATGACAGCAAAGTGA; 3', AGGGGGAAACCTTTTACAGA) and was ligated into a plasmid vector (PGEM T-Easy, Promega). Northern blot analysis confirmed that this probe bound to only one transcript which was of an identical size to that which hybridized with the longer 416 bp cDNA probe isolated by DD RT-PCR. The sense and antisense RNA probes were generated using the T7 and SP6 promoters and labeled by incorporation of 35 S-dUTP. The labeled probe and Hybridization with the sense RNA probe was used to assess non-specific hybridization. Statistical Analysis: Data are presented as means ± SEM. The total integrated density of the CALM2 mRNA transcript was divided by the total integrated density of the 18S rRNA band for each lane to adjust for minor RNA loading differences between lanes. Statistical comparisons between control fetuses and fetuses exposed to TO were only made between samples run in the same Northern or Western blot and, therefore, were subjected to the same hybridization and exposure conditions. Differences between the CALM2 mRNA levels in control fetuses and fetuses exposed to 2, 4 or 10 days of TO were compared using a Students unpaired t-test. Calmodulin protein levels in control fetuses and fetuses exposed to 2, 4 and 10 days of TO were run on the same blot and, therefore, differences between the groups were analysed by a one-way ANOVA. The accepted level of significance for all the statistical analyses was P<0.05. CALM2 mRNA levels in fetuses exposed to TO were expressed as a percentage of the mean control values run on the same blot to depict the time course for the changes in CALM2 mRNA levels following obstruction of the fetal trachea.
Western blot analysis:

Results
Differential Display RT-PCR and 5' RACE: Five arbitrary 5' primers and 1 anchored 3'
primer were used to identify ~50 differentially expressed bands. Six bands were chosen and successfully subcloned and differential expression confirmed by Northern blot analysis. All 6 cDNA fragments were sequenced, but only one contained coding region and could be identified; the other 5 have been stored for further analysis. The identified cDNA fragment was 416 bp in length and was found to partially encode for calmodulin. Based on the human calmodulin sequence, the cDNA fragment comprised 303 bp of coding sequence and 113 bp of 3' untranslated region. The 303 bp coding sequence ( Fig. 1) corresponded to amino acids 49 to 149 of human calmodulin. The 5' arbitrary primer used for amplification of the cDNA subset from which the calmodulin fragment was obtained was 5'-TCGGTCATAG-3', which was present at the 5' end of the PCR fragment; the anchored primer T12VA (T12GA) was present at the 3' end of the PCR fragment (Fig. 1) .
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There are three human calmodulin genes and the sequence we initially identified was thought to be the ovine homologue of CALM2, as it had 96% (393/402) homology with human CALM2 and only 86% (266/307) homology with human CALM1 and 82% (218/263) homology with human CALM3. Extension of this differentially expressed clone in the 5' direction, using 5' RACE, yielded the remaining 155 bp of coding region for CALM2 (458 bp in total; Fig. 1 ) in addition to 68 nucleotides of the 5'untranslated region (UTR). Identification of this sequence confirmed that the differentially expressed clone we had isolated was ovine CALM2. Ovine CALM2 cDNA shares 96% (594/615) homology with hCALM2, 85%
(395/464) homology with hCALM1 and 82% (373/453) homology with hCALM3.
Northern blot analysis:
Differential expression of CALM2 mRNA in response to an increase in fetal lung expansion was confirmed by Northern blot and in situ hybridization analyses. The isolated CALM2 cDNA hybridized with a single RNA transcript of 1.4 kb ( Fig.   2A ). At 36 hours after obstruction of the left bronchus, CALM2 mRNA levels in left lung tissue (expanded) were increased to 172 ± 7% of the mean control value measured in tissue from the right lung ( Fig. 2A) .
In separate groups of fetuses subjected to TO, CALM2 mRNA levels were significantly increased from 204 ± 38 in control fetuses to 329 ± 11 at 2 days after TO (Figs. (Fig. 3A) .
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In situ hybridization analysis: Using the specific antisense RNA probe for CALM2, the proportion of lung cells labeled increased from 10.3 ± 1.0% in control fetuses to 21.4 ± 6.3% in fetuses exposed to 2 days of TO (Fig. 3B) . The fetal lung cells expressing CALM2
included type-II epithelial cells, fibroblasts and endothelial cells.
Western blot analysis:
A single protein band of 17kD was detected using the anticalmodulin monoclonal antibody (Fig 1C) . Mean calmodulin levels in lung tissue tended to increase from 122.7 ± 17.3 in control fetuses to 156.5 ± 17.7 in fetuses exposed to 2 days of TO (Fig 4) , although the difference was not significant (P=0.11). Mean calmodulin levels returned to control values by 4 days of TO (113.2 ± 10.6) and remained at these levels at 10 days of TO (118.7 ± 15.5).
Discussion
Our results demonstrate that the technique of differential display was successful in detecting a previously undescribed change in the mRNA levels for CALM2 in response to 
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Our initial identification of CALM2 was based on a high degree of homology between the differentially expressed cDNA fragment we isolated and the previously described sequence for mammalian calmodulin. Extension of this cDNA fragment in the 5' direction, using 5' RACE, yielded the remainder of the coding sequence for ovine CALM2, confirming that the differentially expressed cDNA fragment originally isolated encoded CALM2 (Fig 1) .
All 3 mammalian calmodulin genes encode for an identical 149 amino acid protein and demonstrate a high level of homology between species (1). Indeed, we found that the cDNA sequence for ovine CALM2 shares a high degree of homology (96%; 37) with human CALM2 and a lesser degree of homology with human CALM1 (85%;33) and human CALM3 (82%;7). Calmodulin is the main calcium signaling mechanism for eukaryotic cells and it binds calcium ions to form a Ca+/calmodulin complex. This, in turn, binds and inactivates autoinhibitory domains in many important protein kinases (1). Thus, calmodulin can act as a permissive factor for the function of target proteins, including some protein kinases involved in growth signaling pathways (21) . In particular, calmodulin has been shown to play an essential role in the G1 to S phase transition in cell growth (19) and many cellular regulatory cascades rely on calmodulin for their function (21).
The transcriptional regulation of calmodulin's expression is complex as it is encoded by multiple genes, which probably reflects its involvement in a diverse variety of cellular pathways. In mammals, calmodulin is encoded by three separate genes (CALM1, CALM2
and CALM3), each with unique promoter and intron regions (7;14;28;37;40). The five transcripts generated by the 3 genes predominantly differ in their 5' and 3' UTR, share nucleotide homology of ~80% in their coding region, but all encode for an identical 149 amino acid protein (7) . As each of the three calmodulin genes are independently regulated, the levels of each individual transcript varies in a tissue and growth stage specific manner.
Based on the sequence of the cDNA fragment isolated, the differentially expressed 1.4kb calmodulin transcript we detected by Northern blot analysis is a product of the CALM2 gene LCMP-00202-2001 R2 15 (37) . This is the first evidence to indicate that CALM2 may be the predominant calmodulin gene involved in regulating expansion-induced fetal lung growth and development.
Previous in vitro experiments, involving antisense transcripts for calmodulin (6) Our finding that CALM2 was differentially expressed in response to an increase in fetal lung expansion and that the changes in CALM2 mRNA levels closely parallel the changes in DNA synthesis rates in response to an increase in lung expansion, supports the concept that calmodulin plays an important role in expansion-induced growth and development of the fetal lung. The mechanisms by which an increase in fetal lung expansion stimulates fetal lung growth and development are largely unknown (12) , but our findings, in combination with the findings of previous studies (30, 38, 39) , indicate that increased intracellular calmodulin levels, via activation of the CALM2 gene, may play an important role. Although it has been widely speculated that production and release of growth factors, which act in a local paracrine fashion, mediate the cellular proliferation induced by LCMP-00202-2001 R2 16 increased lung stretch (11, 12, 18) , intercellular chemical signaling may not be the predominant regulatory mechanism. Indeed, it is possible that mechanical coupling between adjacent cells and between cells and the extracellular matrix is the predominant stimulus.
This, in turn, may directly activate an intracellular cascade of which calmodulin plays a central role. Although it was not possible to quantify cell types within the fetal lung that had specifically increased CALM2 expression in this study, we note that CALM2 expression was localised in type-II epithelial cells, fibroblasts and endothelial cells in both control fetuses and fetuses exposed to 2 days of TO. We have previously found that all of these cell types proliferate in response to an increase in fetal lung expansion (27) , indicating that increased CALM2 expression may be closely linked with cellular proliferation within the lung.
The involvement of calmodulin in expansion-induced lung growth may not be restricted to the fetus as calmodulin levels increase during accelerated lung growth induced by hemi-pneumonectomy in immature rats (27) . The increase in lung growth following hemipnuemonectomy is thought to be expansion dependent (31) and the time course for the change in calmodulin levels (29) is very similar to that observed in this study following TO.
That is, the greatest increase in calmodulin levels occurred at 2 days after hemipneumonectomy and coincided with a large increase in pulmonary DNA synthesis rates.
Furthermore, the administration of TFP reduced the increase in calmodulin activity and the increase in lung growth following hemi-pneumonectomy (29) . However, the precise role that calmodulin may play in the intracellular pathways leading to cellular proliferation in the lung is currently unknown, but warrants further investigation.
Although calmodulin protein levels tended to be increased in fetal lung tissue at 2 days of TO, the increase in CALM2 expression, as determined by both Northern blot and in situ hybridization analyses, was far greater than the increase in protein levels. There are a number of possible explanations for this discrepancy, including the possibility of reduced translation of this gene product. However, as the protein encoded by each of the 3 CALM LCMP-00202-2001 R2 17 genes is identical and will be detected by the antibody, we consider it more likely that expression and translation into protein from the CALM1 and CALM3 genes (which may be unaltered or reduced by TO) may mask changes in whole tissue calmodulin levels associated with alterations in CALM2 expression. It is unknown whether CALM1 and CALM3 genes are differentially regulated by alterations in fetal lung expansion, but requires investigation.
In summary, we have shown that CALM2 is differentially expressed in response to an increase in fetal lung expansion and that the change in expression pattern closely parallels the change in DNA synthesis rates under these conditions. It is now recognised that calmodulin plays an important role in the processes controlling cell replication, indicating that intracellular calmodulin levels may, in part, mediate the expansion-induced cellular proliferation within the fetal lung. 
